Brief: Dicot Conducts Rights Issue Of About SEK 20.3 Mln

Dicot Pharma AB

23/07/2019 08:46

July 23 (Reuters) - Dicot AB  DICOT.TE :
    * CONDUCTS A RIGHTS ISSUE OF APPROXIMATELY SEK 20.3 MILLION
AND
ANNOUNCES A BRIDGE FINANCING
    * DICOT HAS ENTERED INTO AN AGREEMENT REGARDING A SHORT-TERM
BRIDGE LOAN OF SEK 4 MILLION
    * UPON FULL SUBSCRIPTION OF RIGHTS ISSUE, DICOT WILL RECEIVE
APPROXIMATELY SEK 20.3 MILLION, BEFORE ISSUE COSTS
    * SUBSCRIPTION PERIOD FOR SUBSCRIPTION OF UNITS WILL BE FROM
SEPTEMBER 3, 2019 TO SEPTEMBER 17, 2019
    * SUBSCRIPTION PRICE IS SEK 2.60 PER UNIT
    * COMPANY IS CARRYING OUT RIGHTS ISSUE IN ORDER TO FINANCE
ON-GOING PRE-CLINICAL STUDIES OF ITS LEAD DRUG CANDIDATE FOR
TREATMENT OF SEXUAL DYSFUNCTIONS AND PREPARATIONS FOR UPCOMING
PHASE 1 CLINICAL STUDY
    * TO SECURE COMPANY'S SHORT-TERM WORKING CAPITAL
REQUIREMENTS,
COMPANY HAS ENTERED INTO AN AGREEMENT REGARDING A SHORT-TERM
BRIDGE LOAN OF SEK 4 MILLION
    * SUBSCRIPTION PERIOD FOR SUBSCRIPTION OF SHARES USING
WARRANTS
WILL BE FROM OCTOBER 1, 2020 TO OCTOBER 15, 2020
    * RIGHTS ISSUE CONSISTS OF A MAXIMUM OF 7,790,823 NEW SHARES
AND
7,790,823 NEW WARRANTS

Source text for Eikon:  ID:nWkr7xZ3Vq 
Further company coverage:  DICOT.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))